The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Bio-MEMS & Microfluidics-Global Market Insights and Sales Trends 2024
Synopsis
Overall world revenue for Bio-MEMS and Microfluidics will have a strong revenue growth through to 2027.The increasing prevalence of neurological conditions, increase in diagnostic procedures in emerging economies and increasing ageing population will increase sales to 2027.
The global Bio-MEMS & Microfluidics market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Bio-MEMS & Microfluidics in various end use industries. The expanding demands from the Pharmaceutical Industry, Medical, Research Centres and Others, are propelling Bio-MEMS & Microfluidics market. Implantable Bio-MEMS, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Injectable Bio-MEMS segment is estimated at % CAGR for the next seven-year period.
There will be growth in both established and in developing countries. Our analyses show that the developing markets, China and India in particular, will continue to achieve high revenue growth to 2027. Developments worldwide in medical device regulation, especially in the US and Japan will influence the market.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Bio-MEMS & Microfluidics, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Bio-MEMS & Microfluidics market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Bio-MEMS & Microfluidics market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Bio-MEMS & Microfluidics sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Bio-MEMS & Microfluidics covered in this report include Abbott Diagnostics, Nova Biomedical, Danaher, Thermo Fisher Scientific, Medtronic, Boston Scientific, ROCHE, Johnson & Johnson and Becton, Dickinson, etc.
The global Bio-MEMS & Microfluidics market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Abbott Diagnostics
Nova Biomedical
Danaher
Thermo Fisher Scientific
Medtronic
Boston Scientific
ROCHE
Johnson & Johnson
Becton, Dickinson
Global Bio-MEMS & Microfluidics market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Bio-MEMS & Microfluidics market, Segment by Type:
Implantable Bio-MEMS
Injectable Bio-MEMS
Other Devices
Global Bio-MEMS & Microfluidics market, by Application
Pharmaceutical Industry
Medical
Research Centres
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Bio-MEMS & Microfluidics companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Overall world revenue for Bio-MEMS and Microfluidics will have a strong revenue growth through to 2027.The increasing prevalence of neurological conditions, increase in diagnostic procedures in emerging economies and increasing ageing population will increase sales to 2027.
The global Bio-MEMS & Microfluidics market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Bio-MEMS & Microfluidics in various end use industries. The expanding demands from the Pharmaceutical Industry, Medical, Research Centres and Others, are propelling Bio-MEMS & Microfluidics market. Implantable Bio-MEMS, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Injectable Bio-MEMS segment is estimated at % CAGR for the next seven-year period.
There will be growth in both established and in developing countries. Our analyses show that the developing markets, China and India in particular, will continue to achieve high revenue growth to 2027. Developments worldwide in medical device regulation, especially in the US and Japan will influence the market.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Bio-MEMS & Microfluidics, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Bio-MEMS & Microfluidics market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Bio-MEMS & Microfluidics market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Bio-MEMS & Microfluidics sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Bio-MEMS & Microfluidics covered in this report include Abbott Diagnostics, Nova Biomedical, Danaher, Thermo Fisher Scientific, Medtronic, Boston Scientific, ROCHE, Johnson & Johnson and Becton, Dickinson, etc.
The global Bio-MEMS & Microfluidics market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Abbott Diagnostics
Nova Biomedical
Danaher
Thermo Fisher Scientific
Medtronic
Boston Scientific
ROCHE
Johnson & Johnson
Becton, Dickinson
Global Bio-MEMS & Microfluidics market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Bio-MEMS & Microfluidics market, Segment by Type:
Implantable Bio-MEMS
Injectable Bio-MEMS
Other Devices
Global Bio-MEMS & Microfluidics market, by Application
Pharmaceutical Industry
Medical
Research Centres
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Bio-MEMS & Microfluidics companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Bio-MEMS & Microfluidics
1.1 Bio-MEMS & Microfluidics Market Overview
1.1.1 Bio-MEMS & Microfluidics Product Scope
1.1.2 Bio-MEMS & Microfluidics Market Status and Outlook
1.2 Global Bio-MEMS & Microfluidics Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Bio-MEMS & Microfluidics Market Size by Region (2018-2029)
1.4 Global Bio-MEMS & Microfluidics Historic Market Size by Region (2018-2023)
1.5 Global Bio-MEMS & Microfluidics Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Bio-MEMS & Microfluidics Market Size (2018-2029)
1.6.1 North America Bio-MEMS & Microfluidics Market Size (2018-2029)
1.6.2 Europe Bio-MEMS & Microfluidics Market Size (2018-2029)
1.6.3 Asia-Pacific Bio-MEMS & Microfluidics Market Size (2018-2029)
1.6.4 Latin America Bio-MEMS & Microfluidics Market Size (2018-2029)
1.6.5 Middle East & Africa Bio-MEMS & Microfluidics Market Size (2018-2029)
2 Bio-MEMS & Microfluidics Market by Type
2.1 Introduction
2.1.1 Implantable Bio-MEMS
2.1.2 Injectable Bio-MEMS
2.1.3 Other Devices
2.2 Global Bio-MEMS & Microfluidics Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Bio-MEMS & Microfluidics Historic Market Size by Type (2018-2023)
2.2.2 Global Bio-MEMS & Microfluidics Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Bio-MEMS & Microfluidics Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Bio-MEMS & Microfluidics Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Bio-MEMS & Microfluidics Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Bio-MEMS & Microfluidics Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Bio-MEMS & Microfluidics Revenue Breakdown by Type (2018-2029)
3 Bio-MEMS & Microfluidics Market Overview by Application
3.1 Introduction
3.1.1 Pharmaceutical Industry
3.1.2 Medical
3.1.3 Research Centres
3.1.4 Others
3.2 Global Bio-MEMS & Microfluidics Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Bio-MEMS & Microfluidics Historic Market Size by Application (2018-2023)
3.2.2 Global Bio-MEMS & Microfluidics Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Bio-MEMS & Microfluidics Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Bio-MEMS & Microfluidics Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Bio-MEMS & Microfluidics Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Bio-MEMS & Microfluidics Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Bio-MEMS & Microfluidics Revenue Breakdown by Application (2018-2029)
4 Bio-MEMS & Microfluidics Competition Analysis by Players
4.1 Global Bio-MEMS & Microfluidics Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Bio-MEMS & Microfluidics as of 2022)
4.3 Date of Key Players Enter into Bio-MEMS & Microfluidics Market
4.4 Global Top Players Bio-MEMS & Microfluidics Headquarters and Area Served
4.5 Key Players Bio-MEMS & Microfluidics Product Solution and Service
4.6 Competitive Status
4.6.1 Bio-MEMS & Microfluidics Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Abbott Diagnostics
5.1.1 Abbott Diagnostics Profile
5.1.2 Abbott Diagnostics Main Business
5.1.3 Abbott Diagnostics Bio-MEMS & Microfluidics Products, Services and Solutions
5.1.4 Abbott Diagnostics Bio-MEMS & Microfluidics Revenue (US$ Million) & (2018-2023)
5.1.5 Abbott Diagnostics Recent Developments
5.2 Nova Biomedical
5.2.1 Nova Biomedical Profile
5.2.2 Nova Biomedical Main Business
5.2.3 Nova Biomedical Bio-MEMS & Microfluidics Products, Services and Solutions
5.2.4 Nova Biomedical Bio-MEMS & Microfluidics Revenue (US$ Million) & (2018-2023)
5.2.5 Nova Biomedical Recent Developments
5.3 Danaher
5.3.1 Danaher Profile
5.3.2 Danaher Main Business
5.3.3 Danaher Bio-MEMS & Microfluidics Products, Services and Solutions
5.3.4 Danaher Bio-MEMS & Microfluidics Revenue (US$ Million) & (2018-2023)
5.3.5 Thermo Fisher Scientific Recent Developments
5.4 Thermo Fisher Scientific
5.4.1 Thermo Fisher Scientific Profile
5.4.2 Thermo Fisher Scientific Main Business
5.4.3 Thermo Fisher Scientific Bio-MEMS & Microfluidics Products, Services and Solutions
5.4.4 Thermo Fisher Scientific Bio-MEMS & Microfluidics Revenue (US$ Million) & (2018-2023)
5.4.5 Thermo Fisher Scientific Recent Developments
5.5 Medtronic
5.5.1 Medtronic Profile
5.5.2 Medtronic Main Business
5.5.3 Medtronic Bio-MEMS & Microfluidics Products, Services and Solutions
5.5.4 Medtronic Bio-MEMS & Microfluidics Revenue (US$ Million) & (2018-2023)
5.5.5 Medtronic Recent Developments
5.6 Boston Scientific
5.6.1 Boston Scientific Profile
5.6.2 Boston Scientific Main Business
5.6.3 Boston Scientific Bio-MEMS & Microfluidics Products, Services and Solutions
5.6.4 Boston Scientific Bio-MEMS & Microfluidics Revenue (US$ Million) & (2018-2023)
5.6.5 Boston Scientific Recent Developments
5.7 ROCHE
5.7.1 ROCHE Profile
5.7.2 ROCHE Main Business
5.7.3 ROCHE Bio-MEMS & Microfluidics Products, Services and Solutions
5.7.4 ROCHE Bio-MEMS & Microfluidics Revenue (US$ Million) & (2018-2023)
5.7.5 ROCHE Recent Developments
5.8 Johnson & Johnson
5.8.1 Johnson & Johnson Profile
5.8.2 Johnson & Johnson Main Business
5.8.3 Johnson & Johnson Bio-MEMS & Microfluidics Products, Services and Solutions
5.8.4 Johnson & Johnson Bio-MEMS & Microfluidics Revenue (US$ Million) & (2018-2023)
5.8.5 Johnson & Johnson Recent Developments
5.9 Becton, Dickinson
5.9.1 Becton, Dickinson Profile
5.9.2 Becton, Dickinson Main Business
5.9.3 Becton, Dickinson Bio-MEMS & Microfluidics Products, Services and Solutions
5.9.4 Becton, Dickinson Bio-MEMS & Microfluidics Revenue (US$ Million) & (2018-2023)
5.9.5 Becton, Dickinson Recent Developments
6 North America
6.1 North America Bio-MEMS & Microfluidics Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Bio-MEMS & Microfluidics Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Bio-MEMS & Microfluidics Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Bio-MEMS & Microfluidics Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Bio-MEMS & Microfluidics Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Bio-MEMS & Microfluidics Market Dynamics
11.1 Bio-MEMS & Microfluidics Industry Trends
11.2 Bio-MEMS & Microfluidics Market Drivers
11.3 Bio-MEMS & Microfluidics Market Challenges
11.4 Bio-MEMS & Microfluidics Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
